BRODALUMAB

2061 reported adverse events

Drug classes: Interleukin-17 Receptor A Antagonist [EPC]

These side effects are most commonly reported by patients taking BRODALUMAB:

# Side effect Count
0 PSORIASIS 504
1 DRUG INEFFECTIVE 240
2 ARTHRALGIA 195
3 INTENTIONAL PRODUCT USE ISSUE 180
4 PSORIATIC ARTHROPATHY 177
5 FATIGUE 174
6 PRODUCT DOSE OMISSION ISSUE 145
7 DISEASE RECURRENCE 139
8 THERAPY INTERRUPTED 139
9 HEADACHE 131
See all common reactions for BRODALUMAB

BRODALUMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PATIENT DISSATISFACTION WITH TREATMENT 80 0.0415
1 ERYTHRODERMIC PSORIASIS 18 0.0218
2 CUTANEOUS T-CELL LYMPHOMA 14 0.0111
3 PRODUCT DISTRIBUTION ISSUE 55 0.0059
4 PUSTULAR PSORIASIS 15 0.0044
5 PSORIATIC ARTHROPATHY 177 0.0044
6 PSORIASIS 504 0.0039
7 SYMPTOM RECURRENCE 22 0.0037
8 DISEASE RECURRENCE 139 0.0029
9 INTENTIONAL PRODUCT USE ISSUE 180 0.0021
See all enriched reactions for BRODALUMAB